isothiocyanates (ITCs). ITCs present strong anti-cancer activities. They are natural potent inducer of phase II detoxification enzymes like glutathione S-transferase and quinone reductase. As a secondary metabolite
rearing phase, key aspects currently under investigation are (i) the microbial dynamics during industrial rearing of mealworm larvae (Tenebrio molitor), house crickets (Acheta domesticus) and grasshoppers (Locusta…
type I and type II. On its basis, we discuss the angular gradients of the pump and emission wave refractive index near the exact phase matching direction, and compare
Based on these, 7 additional patients with other metastatic solid tumors were enrolled into phase-II trial using the expansion dose, the response of which is under evaluation
receptors on basophils and mast cells over a period of several weeks. In multiple Phase II and III clinical studies, omalizumab has been shown to be safe and efficacious
Administration in 2003 for the treatment of moderate-to-severe plaque psoriasis. In Phase I, II and III trials, efalizumab has shown significant improvement in the psoriasis area and severity
storage vacuoles in Kupffer cells and connective tissue, clinical trials were intitiated. A Phase I/II trial showed that regular infusions of recombinant arylsulfatase B were able to reduce urinary ... shoulder range of…
compounds have been used in preregistrative clinical trials or are currently in various Phases (I, II or III) of their progress towards use in HIV-1-infected patients. All drugs
bone marrow-determined cells has remarkable clinical significance and useful advantage. The phase I/II clinical studies have proved that the bone marrow derived mononuclear cells offer variety options; however
very effective as pain killers and anti-inflammatory agents, these belong to the type II category of the biopharmaceutical classification system, indicating that, though these drugs have a relatively high ... melt…
metal ions from aqueous solutions. Effect of the membrane composition on the palladium(II) recovery has been studied. Phosphonium ionic liquids are very interesting group of the ionic liquids ... different metal ions…
phase (IV), poor Sn, Ti and rich Cu zone (III), Ti3Cu4 intermetallic (II) and β-Ti (Cu) phase (I). Shear test results showed that the average shear strength reached
indications has been explored via animal models and Phase I and II clinical studies. Phase II clinical trials have now initiated in methamphetamine and other drug addictions, progressive multiple sclerosis
rates of cytogenetic and molecular responses with only few cases of disease progression in Phase II trials. Five years follow-up of Phase III randomized ENESTnd study demonstrated deep molecular
development costs. Clinical trial simulation can improve decisions made in learning Phase I and Phase II studies, leading to better designs and reduced chance of failure in high-cost, confirmatory ... simulations to…
median size of trials has remained at approximately 100 patients), the number of randomized Phase II trials has increased, and the majority of trials investigate nonsmall- cell lung cancer
pulmonary fibrosis (IPF) by regulatory authorities in the USA and Europe. Results from the Phase II TOMORROW trial and the two replicate Phase III INPULSIS® trials have shown that nintedanib
asthma, is an investigational fully human monoclonal antibody designed to inhibit IL-13. In Phase II studies, tralokinumab improved lung function and had other clinical benefits in those patients with ... there were…
more recently, pimavanserin were demonstrated to be effective in Phase III clinical trials. Phase II studies, open-label trials, case series and case reports have suggested an anti-psychotic efficacy
received therapies known to cause nonmelanoma skin cancer. Noninferiority to mechlorethamine ointment in a Phase II controlled trial led to the US FDA 2013 approval of VALCHLOR™ (mechlorethamine
molecule prolongs plasma half-life and allows for once-weekly administration. Clinical Phase II and III trials show dose-dependent reductions of HbA1c up to 1.6%, reduction in fasting plasma
II studies with an initial doseescalation (proof of mechanism) phase followed by an integrated Phase II (proof of concept) to demonstrate direct clinical benefit could greatly improve the efficiency
lung cancer. Their use in combination with chemotherapy and radiotherapy has been investigated in Phase II and III trials. The use of EGF receptor tyrosine kinase inhibitors in combination with ... chemotherapy and…
trials in advanced non-small-cell lung cancer at 50 mg once daily. In Phase II trials, reduction in tumor size was observed in 90% of patients. The objective response ... were grade 3 and none grade 4. LUX‑Lung 1, one…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.